SEARCH

SEARCH BY CITATION

References

  • 1
    Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment for breast cancer–a Swedish population-based study. Eur J Cancer. 1998; 34: 2068-2075.
  • 2
    Rubino C, Shamsaldin A, Le MG, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat. 2005; 89: 277-288.
  • 3
    Cozen W, Bernstein L, Wang F, Press MF, Mack TM. The risk of angiosarcoma following primary breast cancer. Br J Cancer. 1999; 81: 532-536.
  • 4
    Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001; 92: 172-180.
  • 5
    Yap J, Chuba PJ, Thomas R, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002; 52: 1231-1237.
  • 6
    Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast. Cancer. 2005; 104: 2682-2688.
  • 7
    Surveillance, Epidemiology, and End Results (SEER)/National Cancer Institute. Overview of the SEER Program. Available at: http://seer.cancer.gov/about/ Accessed May 29, 2008.
  • 8
    Fritz AG, Percy C, Jack A, Sobin LH, Parkin MD. International Classification of Diseases for Oncology (ICD-O), 3rd ed. Geneva: World Health Organization; 2000.
  • 9
    National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program. Available at: www.seer.cancer.gov Limited-Use Data (1973-2003). Accessed on May 1, 2007.
  • 10
    Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004; 28: 781-788.
  • 11
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687-1717.
  • 12
    Stewart FW, Treves N. Lymphangiosarcoma in post-mastectomy lymphedema. Cancer. 1948; 1: 64-81.
  • 13
    Galper S, Gelman R, Recht A, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2002; 52: 406-414.
  • 14
    Virtanen A, Pukkala E, Auvinen A. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer. 2006; 118: 1017-1021.
  • 15
    Holt GE, Thomson AB, Griffin AM, et al. Multifocality and multifocal postradiation sarcomas. Clin Orthop Relat Res. 2006; 450: 67-75.
  • 16
    Monroe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer. 2003; 97: 1832-1840.
  • 17
    Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJ. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforseen sequela. Breast Cancer Res Treat. 1998; 47: 101-109.
  • 18
    Marchal C, Weber B, de Lafontan B, et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys. 1999; 44: 113-119.
  • 19
    Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer. 2005; 104: 856-863.
  • 20
    Brenn T, Fletcher CD. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006; 48: 106-114.